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Ion channel receptors are a vital component of nervous system signaling, allowing rapid
and direct conversion of a chemical neurotransmitter message to an electrical current.
In recent decades, it has become apparent that ionotropic receptors are regulated by
protein-protein interactions with other ion channels, G-protein coupled receptors and
intracellular proteins. These other proteins can also be modulated by these interactions
with ion channel receptors. This bidirectional functional cross-talk is important for critical
cellular functions such as excitotoxicity in pathological and disease states like stroke,
and for the basic dynamics of activity-dependent synaptic plasticity. Protein interactions
with ion channel receptors can therefore increase the computational capacity of neuronal
signaling cascades and also represent a novel target for therapeutic intervention in
neuropsychiatric disease. This review will highlight some examples of ion channel receptor
interactions and their potential clinical utility for neuroprotection.
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Efficient neurotransmission requires the precise interplay of
various neurotransmitter receptors at pre- and post-synaptic
compartments. Ligand-gated ion channels play a central role in
intercellular communication in the nervous system. Ion chan-
nels are the cellular machinery for ion flux across the membrane
and therefore the basis of electrical excitation of neurons. Ligand-
gated ion channels are oligomeric protein assemblies that convert
a chemical signal into an ion flux through the post-synaptic
membrane, and are involved in basic brain functions such as
attention, learning, andmemory (Ashcroft, 2006). This paper will
review some interactions between ionotropic receptors and other
proteins that affect signaling, metabolism, and trafficking. We
will detail some of the interactions between G-protein coupled
receptors and ion channels, ion channels with intracellular pro-
teins, and ion channels with other ion channels. Specifically, we
will discuss how these receptor-protein interactions may help to
understand pathology of the nervous system, and offer the hope
of new treatment targets for neuropsychiatric disease.
Most eukaryotic membrane channels are composed of several
subunits. Pentameric ligand-gated ion channels have five sub-
units arranged in a pseudosymmetric rosette around the centrally
located ion channel pore. Each subunit consists of an extracellular
domain that contains the ligand-binding site and a transmem-
brane ion-pore domain (Kozuska and Paulsen, 2012). The agonist
binding site is located at the boundary between subunits in the
extracellular domain whereas the ion pore is formed by the
transmembrane helices M2, which differentiate axial cationic and
anionic channels (Dacosta and Baenziger, 2013).
The modular construction of ionotropic receptors increases
the diversity of ligand binding and ion selectivity through the
mixing and matching of various subunits (Rojas and Dingledine,
2013). Various other proteins are involved in controlling the
type and position of particular subunits in a given channel, as
well as the function of the function of the assembled channel.
Thus, the function of many receptor proteins can only be fully
understood in the context of their interactions with other pro-
teins, the “interactome” (Li et al., 2013a). Through this extensive
protein network, the binding of agonist to an ionotropic recep-
tor can exert effects beyond simple current flow, including gene
transcription, cytoskeletal rearrangement, and protein synthesis,
degradation and transport.
The ligand-gated ion channel superfamily includes nico-
tinic acetylcholine receptors (nAChRs), adenosine triphos-
phate (ATP) receptors, γ-aminobutyric acid (GABA), gluta-
mate, glycine, and 5-hydroxytryptamine (5-HT) receptors (Dent,
2010). The “Cys-loop” sub-family includes the ionotropic recep-
tors for nicotine, GABA, glycine, and 5-HT. “Pore-loop” channels
include inwardly-rectifying potassium channels and the glu-
tamate receptors of the AMPA (α-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid) subtype and NMDA (N-methyl-D-
aspartate) receptors (Connolly andWafford, 2004). The structure
and basic features of several important ion channel types is briefly
reviewed below to provide some background, before discussing
ion channel interactions with other proteins.
AMPA receptors are the major mediator of fast excitatory
synaptic transmission in the mammalian central nervous system.
Most of these ionotropic glutamate receptors are permeable to
calcium and other cations, thus facilitating depolarization of the
cell membrane. AMPA receptors contain four subunits, consist-
ing of two dimers formed by combinations of four pore-forming
subunits GluA 1–4. GluA 1/2, and GluA 2/3 are the predominant
AMPA receptor types (Anggono and Huganir, 2012). Each sub-
unit is an integral membrane protein with an extracellular amino
terminal domain, three membrane-spanning domains (M1, M3,
and M4), a hydrophobic hairpin domain (M2) that forms the
channel pore, and three intracellular domains: Loop1, Loop2, and
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the carboxyl tail. Although the carboxyl tail is crucial for recep-
tor trafficking and function, other intracellular domains also play
an important role in the regulation of AMPA receptor traffick-
ing (Rojas and Dingledine, 2013). The pore lining domain also
influences the AMPA receptor trafficking, early in the secretory
pathway.
NMDA receptors are also ionotropic glutamate receptors per-
meable to calcium and sodium, and are critical for synaptic
plasticity, learning, and memory. These receptors are involved
nicotine addiction and neurological disorders such as ischemic
stroke (Dingledine et al., 1999; Albensi, 2007). NMDA channel
opening is gated by several elements, including the binding of glu-
tamate to the NR2 subunit, a co-ligand glycine which binds to a
separate site on theNR1 subunit, and the removal of amagnesium
ion block by depolarization. Thus NMDA channels require both
agonist stimulation and depolarization of the post-synaptic mem-
brane for current flow, effectively detecting coincident pre- and
post-synaptic activation. Like AMPA receptors, NMDA receptors
consist of four subunits, two of which are obligatory GluN1 and
two which are modulatory GluN2. These subunits are present in
various isoforms that in the NR1 subunit are generated by alter-
native splicing of the GRIN1 gene. The GluN2 subunits are each
encoded by different genes and the subunits are named: NR2A,
B, C, and D (Durand et al., 1992; Sugihara et al., 1992; Hollmann
et al., 1993; Michaelis, 1998). The exact subunit composition of
native NMDARs remains unknown, but it has been suggested that
native NMDARs in rat hippocampus largely contain NR1/2A sub-
units. The intracellular C-terminal (Allison et al., 1998) contains
potential sites of protein phosphorylation by different kinases,
and motifs for interacting with various protein partners.
For pentameric ligand-gated ion channels such as the GABAA
receptor, each subunit contains an extensive N-terminal extra-
cellular domain and a short extracellular C-terminal sequence
containing the ligand binding sites. Structurally, each recep-
tor is composed of four closely-spaced transmembrane domains
including the ion channel wall primarily in M2, and a vari-
able length cytoplasmic loop between M3 and M4. With both
the N-terminus and C-terminus of receptor subunits extend-
ing outside the cell membrane, the intracellular M3-M4 loop
becomes the most important domain interacting with the
intracellular environment. The M3-M4 intracellular loop (IL2)
contains protein-protein interaction domains involved in regu-
lating synaptic localization and intracellular trafficking (Maksay,
2009). Despite being highly variable in length and amino acid
sequence, the IL2 loop usually contains numerous regulatory
motifs and binding sites that differ in each subunit isoform.
Moreover, this IL2 loop usually contains sites for phosphory-
lation, palmitoylation, ubiquitination and other modifications
that modulate protein interactions and eventually determine
the clustering, stability, and function of ligand-gated ion
channels.
Within the central nervous system (CNS), nicotine acts on
nicotinic receptors (nAChRs) to initiate various physiological and
pathological processes at the cellular and circuit level. Similar to
the NMDAR, nAChR is also a ligand-gated ion channel receptor
with high Ca2+ permeability. The pentameric nAChR has a num-
ber of different subtypes, each with individual pharmacological
and physiological profiles and a distinct anatomical distribution
in the brain (Gotti et al., 2009). There are 11 neuronal nAChR
subunits identified in mammals, including eight α(α2 –α9) and
three β (β2– β4). Unlike NMDAR, nAChR can exist as both
hetero-metric and homo-metric-assemblies of these subunits
(Albuquerque et al., 2009). In rodents, the β2 subunit is found
throughout the CNS, mostly as part of the α4β2 heteromeric
receptor, which exhibits high affinity for nicotine. The second
common AChR isoform is the α7 homopentamer, expressed
mainly in the cortex, hippocampus, and limbic areas.
Numerous proteins are known to bind to the different sub-
units of pentameric ligand-gated ion channel receptors at specific
subcellular localizations. These interacting proteins can both
modulate ion channel function and influence the localization of
the channel in the cell and in the membrane. There are several
major categories of proteins that ligand-gated ion channels
interact with: G-protein coupled receptors, intracellular proteins,
and other ligand-gated ion channels (Kittler and Moss, 2003; Li
et al., 2012; Rojas and Dingledine, 2013). We will discuss each
of these types of interaction with examples drawn from our
previous work.
LIGAND-GATED ION CHANNEL INTERACTIONS WITH
G-PROTEIN COUPLED RECEPTORS
There are several ion channel interactions with G-protein coupled
receptors reported by our group, all involving dopamine recep-
tors: D5-GABAA (Liu et al., 2000), D1-NMDA (Lee et al., 2002;
Pei et al., 2004), and D2-AMPA (Zou et al., 2005).
First discovered in 2000, the interaction between γ-
aminobutyric acid A receptors and the dopamine D5 receptor was
one of the earliest examples of interactions between metabotropic
and ionotropic receptors (Liu et al., 2000). The GABAA receptor
is the major inhibitory neurotransmitter receptor that conducts
chloride ions, resulting in hyperpolarization of the cell mem-
brane and thus inhibiting neuron depolarization. The second
intracellular loop of the GABAA γ2 (short) receptor subunit
binds directly to the carboxy-terminus of the D5 receptors. This
interaction reduces D5 receptor-mediated cAMP accumulation
without altering affinity of the D5 for endogenous and experi-
mental ligands. Conversely, activation of D5 receptors reduces
GABAA currents and this is not dependent on PKC or PKA.
Because these two receptors co-localize in hippocampal and
cortical neurons, the bi-directional modulation is potentially
important for a number of behaviors and brain disorders. A
notable feature of this reciprocal modulation is that it is inde-
pendent of the classical signaling pathways for each individual
receptor.
The interaction between the D1 and NMDA receptor involves
direct binding between the carboxy termini of the D1 recep-
tor and the NR1-1a and NR2A subunits of the NMDA receptor
(Lee et al., 2002). Because there are two interacting components
in the NMDA receptor, the functional consequences are more
complicated than with the D5-GABAA interaction. Although
the D1-NMDA interaction occurs in the absence of D1 recep-
tor agonist stimulation, the D1 agonist SKF 81297 decreases the
amount of D1-NMDA complex. However, the agonist affects only
D1-NR1-1a binding, not the D1-NR2A interaction.
Frontiers in Cellular Neuroscience www.frontiersin.org May 2014 | Volume 8 | Article 125 | 2
Li et al. Ligand-gated ion channel interacting proteins
Similar to the D5-GABAA interaction, D1 agonist stimula-
tion reduces NMDA currents as well as reducing the slope of the
current-voltage curve without altering the reversal potential. This
decrease in NMDA conductance is accompanied by a reduction
in NMDA cell surface expression. It is independent of PKA/PKC
pathways and is mediated by the D1 interaction with the NR2A
subunit. The D1-NR1-1a interaction mediates neuroprotective
effects of D1 receptor activation, and these effects are not depen-
dent on G-protein signaling but rather are dependent on a PI-3-
kinase mechanism. The proposed model is that agonist activation
of D1 receptors promotes dissociation of the D1-NR1-1a inter-
action, allowing the NR1-1a carboxy tail to bind CaM and PI-3
kinase, thereby initiating protective cellular cascades. Conversely,
the D1 receptor is also regulated by NMDA receptor activation,
which increases cell surface D1 receptor expression, and enhances
cAMP accumulation in a SNARE-dependent fashion (Pei et al.,
2004).
Dopamine D1 receptors also have a direct physical interaction
with N-type calcium channels (Kisilevsky et al., 2008). In pre-
frontal cortex neurons dopamine D1 receptor activation reduced
calcium influx through voltage-gated calcium channels, likely
through both voltage-dependent G-protein-mediated pathways
and through PKA-mediated pathways. The D1-Cav2.2 channel
interaction also regulates cell surface expression and distribu-
tion of the channel, allowing effective dopaminergic regulation
of backpropogating action potentials that are mediated by N-type
calcium channels.
LIGAND-GATED ION CHANNEL INTERACTIONS WITH
INTRACELLULAR PROTEINS
The second category of ion channel interactions to be considered
is with intracellular proteins. For the GABAA receptor, mul-
tiple interacting proteins have been characterized, that play a
role in cytoskeletal coupling by gephyrin, radixin, and F-actin
and in signaling modulation by RAFT1 and collybistin (Chen
and Olsen, 2007). The functional characteristics of this modu-
lation are related to their subcellular localization with receptors.
For example, GABARAP, GODZ, and Plic1 interact with the
intracellular parts of the GABAA receptor, while GRIP1 and
gephyrin are localized to sub-membrane and intracellular com-
partments.
Our group has recently reported an interaction between
the N-terminus of the GluR2 sub-unit of the AMPA recep-
tor and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
(Wang et al., 2012; Zhai et al., 2013). GAPDH is a metabolic
enzyme that participates in glycolysis and also plays a role in
apoptosis (Tarze et al., 2007). AMPA receptor activation by ago-
nist increases formation of the GluR2-GAPDH complex and
promotes cellular internalization. Blocking this interaction with
a peptide protects cells against glutamatergic excitotoxicity and
ischemia-induced neuronal damage. This interaction is therefore
of potential clinical interest for the treatment of ischemic stroke
or other conditions with neuronal damage.
Another ion channel-protein interaction that has been of inter-
est because of neuroprotective effects is between the PDZ domain
of post-synaptic density 95 (PSD95) protein and carboxyl termi-
nus of the NMDANR2 subunit (Kornau et al., 1995; Niethammer
et al., 1996; Cui et al., 2007). This interaction couples NMDA
receptor activation to nitric oxide neurotoxicity (Sattler et al.,
1999), and disrupting this interaction can protect neurons from
excitotoxicity and ischemic brain damage both in vitro and in vivo
(Aarts et al., 2002). PSD-95 also interacts with and suppresses the
tyrosine kinase Src and attenuates Src-mediated NMDA receptor
upregulation (Kalia et al., 2006). Consistent with these findings,
inhibitors of PSD-95 also show neuroprotective effects in animal
models of stroke (Sun et al., 2008).
While several examples of direct interactions between ion
channels and G-protein coupled receptors have been discussed
above, these two types of receptors can also exert functional
crosstalk through indirect interactions. For example, the presy-
naptic voltage-gated calcium channels that influence neurotrans-
mitter release are regulated by G-protein activation and protein
kinase C-dependent phosphorylation through binding to Gβγ
(Zamponi et al., 1997). G-protein modulation of N-type cal-
cium channels also involves syntaxin 1A, a member of the SNARE
protein complex responsible for synaptic vesicle fusion during
neurotransmitter release (Jarvis et al., 2000). An additional mod-
ulator is cysteine string protein or CSP, which also bind to N-type
calcium channels in conjunction with G-proteins to exert a tonic
inhibition of the channel (Magga et al., 2000). In the case of
G-protein activation in inwardly-rectifying potassium channels
(GIRK), the Gβγ directly gates ion channel opening by binding
to the intracellular pore of the channel (Nishida and MacKinnon,
2002).
LIGAND-GATED ION CHANNEL INTERACTIONS WITH OTHER
ION CHANNELS
Ion channel receptors can also interact with other ion chan-
nels, such as the interaction between the α7 nicotinic acetyl-
choline receptors and NMDA receptors (α7nAChR-NMDA) (Li
et al., 2012, 2013b). The carboxy tail of the NMDA receptor
NR2 subunit binds directly with the second intracellular loop
of the α7nACh receptor, and the interaction promotes ERK1/2
phosphorylation. This interaction is of clinical interest since nico-
tine increases formation of the complex, and disrupting the
α7nAChR-NMDA interaction blocks cue-induced reinstatement
of nicotine self-administration in the rat. This behavioral test
is a model of relapse in nicotine addiction, suggesting that the
α7nAChR-NMDA interaction could be a useful target for novel
smoking cessation therapies.
TARGETING LIGAND-GATED ION CHANNEL INTERACTIONS
FOR NEUROPROTECTION
Because of the involvement of ion channel receptors in neuronal
death from excitatory glutamate stimulation, there has been con-
siderable interest in these receptors as therapeutic targets for the
treatment of brain disorders involving neuronal death, such as
ischemic stroke. Ischemic stroke is a major medical problem that
affects millions of people world-wide. Current acute post-stroke
treatment is focused on lysing the clot obstructing arterial blood
flow by using a tissue plasminogen-activator. Due to a very short
time window for effectiveness and the potential for intracranial
bleeding, few patients can benefit from this treatment (Grossman
and Broderick, 2013). Therefore, there is a major need for new
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and safer drugs that can reduce the extent of brain injury from
ischemic stroke.
An alternative strategy for post-stroke treatment is to target
neurotoxicity instead of focusing on the blood vessel blockade,
or in addition to clot lysis. However, preventing excitotoxicity
is difficult because glutamate receptors have a critical role in
many brain functions. AMPA/kainate receptor antagonists such
as NBQX or MPQX can reduce neurological deficits in animal
models of autoimmune damage (Smith et al., 2000), but these
drugs are too toxic for clinical use. Other strategies, such as block-
ing the glycine site of the NMDA receptor for treating ischemic
stroke have been ineffective in improving outcomes (Lees et al.,
2000; Sacco et al., 2001).
The interactions between ionic glutamate receptors and other
proteins such as GluR2-GAPDH and NR2-PSD-95 can improve
cell survival after ischemic insults, and thus represent another
approach to neuroprotective treatments after stroke (Sattler et al.,
1999; Zhai et al., 2013). This strategy is attractive because the basic
signal transducing functions of the channels are not blocked as
they would be by a conventional antagonist. Thus, a more sub-
tle modulation of ion channel function can be achieved, with
the hope of reducing excitotoxicity while sparing normal neuro-
transmission. Those in vitro and animal model experiments used
small interfering peptides to disrupt the channel-protein inter-
actions, but these peptides may not be ideal for human clinical
use. Therefore, an important priority for future research is the
development of suitable drugs targeting the ion channel-protein
interactions involved in excitotoxicity.
In summary, ion channel function is modulated by interac-
tions with other proteins. Various proteins influence the number
and position of particular subunits in the assembled channel,
the dynamics of receptor trafficking and targeting to designated
subcellular areas, as well as the assembly, stability, and turnover
of the receptor on the membrane and in intracellular signaling
pathways. These interactions permit the function of ion channels
to be fine-tuned according to both external stimuli and intra-
cellular states. This network of molecular interactions allows for
complex signal processing by neurons and also reveals new tar-
gets for pharmacological manipulation of neuron function that
may be clinically useful. Knowledge of ion channel interactions
has progressed rapidly and more such interactions are likely to
emerge.
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